<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Circulating DNA (ctDNA) is acknowledged as a potential diagnostic tool for various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, especially when considering the detection of mutations </plain></SENT>
<SENT sid="1" pm="."><plain>Certainly due to lack of normalization of the experimental conditions, previous reports present many discrepancies and contradictory data on the analysis of the concentration of total ctDNA and on the proportion of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-derived ctDNA fragments </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY: In order to rigorously analyse ctDNA, we thoroughly investigated ctDNA size distribution </plain></SENT>
<SENT sid="3" pm="."><plain>We used a highly specific Q-PCR assay and athymic <z:mp ids='MP_0003815'>nude</z:mp> mice xenografted with SW620 or HT29 human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells, and we correlated our results by examining plasma from metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION/SIGNIFICANCE: Fragmentation and concentration of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-derived ctDNA is positively correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> weight </plain></SENT>
<SENT sid="5" pm="."><plain>CtDNA quantification by Q-PCR depends on the amplified target length and is optimal for 60-100 bp fragments </plain></SENT>
<SENT sid="6" pm="."><plain>Q-PCR analysis of plasma samples from xenografted mice and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients showed that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-derived ctDNA exhibits a specific amount profile based on ctDNA size and significant higher ctDNA fragmentation </plain></SENT>
<SENT sid="7" pm="."><plain>Metastatic colorectal patients (n = 12) showed nearly 5-fold higher mean ctDNA fragmentation than healthy individuals (n = 16) </plain></SENT>
</text></document>